Loading news article.

Newsfiscal.ai

GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting

Oct 26, 2026, 09:04 ET · Published

Article summary

GT Biopharma, Inc. announced that it has been selected for an oral presentation at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting.

An excerpt from the original article.

Related companies

GT Biopharma, Inc. Common StockGTBPView stock

Analyzed by WAPE AI.

Preparing English content…

Repost

Comments —

Loading comments…